US Patent Number
The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.
University of Kentucky Research Foundation, Lexington, KY (US)
Ambati, Jayakrishna and Fowler, Benjamin, "Compositions and Methods for Treating Retinal Degradation" (2020). Ophthalmology and Visual Science Faculty Patents. 26.